3 ms·
The bulk of US vaccinations (and EU vaccinations, now) are with Pfizer-Biontec. Biontec which didn't accept development money from the US government, but did f
by rsynnott 6y ago
The bulk of US vaccinations (and EU vaccinations, now) are with Pfizer-Biontec. Biontec which didn't accept development money from the US government, but did from the German government, so I'm not sure how relevant "warp speed" was there, really.
The EU's vaccine woes are down to a combination of being one of two large producers (other is India) not to restrict export of vaccines and precursors (until recently, the EU had exported more doses than it had administered), and the AZ disaster. As of end of Q1 AZ was short 70 million doses for Europe; by end of Q2 based on its own predictions it'll be short around 220 million in total.
Now the EU _could_ have gone all in on Pfizer-Biontec (and Curevac), and poured all the money into mRNA production. But that would have seemed like a pretty bizarre move 6 months ago, when there was a lot of uncertainty over how mRNA manufacture would go.